A novel class of substituted piperidines, pharmaceutical compositions
comprising them and use thereof in the treatment of diseases and
disorders related to the histamine H3 receptor. More particularly, the
compounds are useful for the treatment of diseases and disorders in which
an interaction with the histamine H3 receptor is beneficial.